Vimta Labs Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Vimta Labs için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Life Sciences kazanç büyümesi	22.8%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

Nov 09

There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

Sep 06

It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Jul 12

Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Jun 12

Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

Apr 26

It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

Jan 06

If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Jul 14

Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Nov 06

Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Jun 02

Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Dec 06

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Oct 27

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Jun 29

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Jun 19

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Mar 09

Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?

Jan 20

Did You Miss Vimta Labs' (NSE:VIMTALABS) 87% Share Price Gain?

Dec 30

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Dec 09

Here's What We Learned About The CEO Pay At Vimta Labs Limited (NSE:VIMTALABS)

Nov 17

Vimta Labs Limited's (NSE:VIMTALABS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Oct 21

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Vimta Labs yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NSEI:VIMTALABS - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	3,376	493	143	829	N/A
6/30/2024	3,176	411	N/A	N/A	N/A
3/31/2024	3,193	410	-157	609	N/A
12/31/2023	3,212	413	N/A	N/A	N/A
9/30/2023	3,169	415	1	765	N/A
6/30/2023	3,234	483	N/A	N/A	N/A
3/31/2023	3,190	482	381	879	N/A
12/31/2022	3,109	473	N/A	N/A	N/A
9/30/2022	3,009	488	367	677	N/A
6/30/2022	2,965	453	N/A	N/A	N/A
3/31/2022	2,787	413	203	591	N/A
12/31/2021	2,644	372	N/A	N/A	N/A
9/30/2021	2,557	336	3	496	N/A
6/30/2021	2,396	314	N/A	N/A	N/A
3/31/2021	2,110	214	41	372	N/A
12/31/2020	1,945	137	N/A	N/A	N/A
9/30/2020	1,873	104	176	357	N/A
6/30/2020	1,694	37	N/A	N/A	N/A
3/31/2020	1,811	68	86	243	N/A
12/31/2019	1,914	136	N/A	N/A	N/A
9/30/2019	1,906	140	123	270	N/A
6/30/2019	2,025	200	N/A	N/A	N/A
3/31/2019	2,130	253	226	391	N/A
12/31/2018	2,126	236	N/A	N/A	N/A
9/30/2018	2,071	245	N/A	N/A	N/A
6/30/2018	1,970	218	N/A	N/A	N/A
3/31/2018	1,836	164	N/A	334	N/A
12/31/2017	1,693	134	N/A	N/A	N/A
9/30/2017	1,602	104	N/A	N/A	N/A
6/30/2017	1,552	83	N/A	N/A	N/A
3/31/2017	1,538	106	N/A	239	N/A
12/31/2016	1,468	94	N/A	N/A	N/A
9/30/2016	1,376	74	N/A	N/A	N/A
6/30/2016	1,344	79	N/A	N/A	N/A
3/31/2016	1,247	64	N/A	-10	N/A
12/31/2015	1,202	63	N/A	N/A	N/A
9/30/2015	1,157	59	N/A	N/A	N/A
6/30/2015	1,068	45	N/A	N/A	N/A
3/31/2015	1,073	51	N/A	153	N/A
12/31/2014	1,082	52	N/A	N/A	N/A
9/30/2014	1,140	85	N/A	N/A	N/A
6/30/2014	1,195	114	N/A	N/A	N/A
3/31/2014	1,183	132	N/A	168	N/A
12/31/2013	1,175	130	N/A	N/A	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: VIMTALABS 'un tahmini kazanç büyümesinin tasarruf oranının ( 6.7% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: VIMTALABS 'un kazançlarının Indian pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: VIMTALABS şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: VIMTALABS şirketinin gelirinin Indian pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: VIMTALABS şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: VIMTALABS 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Vimta Labs Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Investor sentiment improves as stock rises 21%

New minor risk - Insider selling

Insider recently sold ₹3.8m worth of stock

Second quarter 2025 earnings released: EPS: ₹7.68 (vs ₹2.85 in 2Q 2024)

Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Vimta Labs Limited to Report Q2, 2025 Results on Nov 08, 2024

Thyrocare Technologies Limited (BSE:539871) completed the acquisition of Diagnostics and and pathological services business of Virnta Labs Limited from Vimta Labs Limited (BSE:524394) for INR 70 million.

New minor risk - Insider selling

There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

Investor sentiment improves as stock rises 17%

Vimta Labs Limited Approves Dividend for the Year Ended March 31, 2024

Vimta Labs Limited to Report Q1, 2025 Results on Jul 17, 2024

It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Upcoming dividend of ₹2.00 per share

Insider recently sold ₹3.5m worth of stock

Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023)

Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Vimta Labs Limited, Annual General Meeting, Jul 18, 2024

Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023)

Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

Investor sentiment improves as stock rises 23%

Investor sentiment deteriorates as stock falls 16%

President recently sold ₹982k worth of stock

Third quarter 2024 earnings released: EPS: ₹4.57 (vs ₹4.62 in 3Q 2023)

Vimta Labs Limited to Report Q3, 2024 Results on Jan 31, 2024

It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

Second quarter 2024 earnings released: EPS: ₹2.85 (vs ₹5.97 in 2Q 2023)

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 17%

Insider recently sold ₹4.9m worth of stock

First quarter 2024 earnings released: EPS: ₹5.51 (vs ₹5.45 in 1Q 2023)

Investor sentiment improves as stock rises 18%

If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Vimta Labs Limited Declares Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹2.00 per share at 0.5% yield

Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00

Vimta Labs Limited to Report Q4, 2024 Results on May 30, 2024

Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00

Full year 2023 earnings released: EPS: ₹21.77 (vs ₹18.70 in FY 2022)

Vimta Labs Limited Recommends Dividend for the Financial Year 2022-2023

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹4.62 (vs ₹5.28 in 3Q 2022)

A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)

President recently sold ₹2.3m worth of stock

Insufficient new directors

Investor sentiment improved over the past week

Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Insider recently sold ₹16m worth of stock

Insufficient new directors

First quarter 2023 earnings released: EPS: ₹5.45 (vs ₹3.65 in 1Q 2022)

Investor sentiment improved over the past week

Upcoming dividend of ₹2.00 per share

Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Vimta Labs Limited Recommends Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings released: EPS: ₹18.70 (vs ₹9.68 in FY 2021)

Vimta Labs Limited Recommends Dividend for the Year 2021-2022

Vimta Labs Limited, Annual General Meeting, Jun 25, 2022

Vimta Labs Limited to Report Q4, 2022 Results on May 12, 2022

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Second quarter 2022 earnings released: EPS ₹4.41 (vs ₹3.41 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.65 (vs ₹0.88 loss in 1Q 2021)

Investor sentiment improved over the past week

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Upcoming dividend of ₹2.00 per share

Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020)